AB ACUMEN BIOPHARMA

Serial Number 86815723
Registration 5071508
702

Registration Progress

Application Filed
Nov 10, 2015
Under Examination
Approved for Publication
Aug 16, 2016
Published for Opposition
Aug 16, 2016
Registered
Nov 1, 2016

Trademark Image

AB ACUMEN BIOPHARMA

Basic Information

Serial Number
86815723
Registration Number
5071508
Filing Date
November 10, 2015
Registration Date
November 1, 2016
Published for Opposition
August 16, 2016
Drawing Code
5000

Status Summary

Current Status
Active
Status Code
702
Status Date
Mar 2, 2023
Registration
Registered
Classes
045

Rights Holder

Acumen BioPharma, LLC

16
Address
6 Howe Court
Pennington, NJ 08535

Ownership History

Acumen BioPharma, LLC

Original Applicant
16
Pennington, NJ

Acumen BioPharma, LLC

Owner at Publication
16
Pennington, NJ

Acumen BioPharma, LLC

Original Registrant
16
Pennington, NJ

Legal Representation

Attorney
Elyse A Marcus

USPTO Deadlines

Next Deadline
469 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2016-11-01)
Due Date
November 01, 2026
Grace Period Ends
May 01, 2027

Application History

28 events
Date Code Type Description Documents
Mar 2, 2023 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL Loading...
Mar 2, 2023 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Loading...
Mar 2, 2023 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Loading...
Aug 15, 2022 E815 I TEAS SECTION 8 & 15 RECEIVED Loading...
Nov 1, 2021 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Nov 1, 2016 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 16, 2016 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 16, 2016 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jul 27, 2016 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jul 8, 2016 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jul 1, 2016 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 23, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jun 23, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jun 21, 2016 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 16, 2016 CNFR R FINAL REFUSAL WRITTEN Loading...
May 16, 2016 GNFR O FINAL REFUSAL E-MAILED Loading...
May 16, 2016 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 11, 2016 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 11, 2016 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 5, 2016 ALIE A ASSIGNED TO LIE Loading...
Apr 22, 2016 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Mar 8, 2016 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 8, 2016 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 8, 2016 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 2, 2016 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 17, 2015 MPMK E NOTICE OF PSEUDO MARK E-MAILED Loading...
Nov 14, 2015 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2015 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 045
Expert witness services in legal matters in the field of pharmaceuticals and patent litigation
First Use Anywhere: Jan 13, 2012
First Use in Commerce: Jan 13, 2012

Additional Information

Design Mark
The mark consists of the stylized wording "ACUMEN BIOPHARMA" to the right of the interconnected, stylized letters "AB". A partial mirror image of the interconnected letters "AB" appear directly below the interconnected letters "AB".
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
ACUMEN BIOPHARMA ACUMEN BIOPHARMA

Classification

International Classes
045

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"BIOPHARMA"